HDB's resale volume dipped 15.8% to 1,313 units sold in February

Its resale price index remained flat as compared to its index in January.

Housing Development Board’s (HDB) resale volume declined 15.8% in February as 1,313 resale flats were sold as compared to the 1,560 transacted units in January, according to SRX Property Price Index.

On a year-on-year basis, resale volume in February was 9.9% higher than 1,195 units resold in 2018.

Furthermore, the resale price index for February remained flat from the prior month. The resale prices of HDB 5 Rooms and HDB Executive recorded a price increase of 0.8% and 0.3% respectively, whilst HDB 4 Rooms prices decreased by 0.3%, and HDB 3 Rooms prices remained unchanged at 0.0%.

Prices in Mature Estates went up by 0.6%, whilst those in Non-Mature Estates decreased by 0.4% as compared to January.

SRX added that the overall median transaction over X-value (T-O-X) is negative $1,000 in February, which means people are underpaying the SRX Property X-Value estimated market value. T-O-X also remained unchanged as compared to January. 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare